S. Michael Imperiale

S.
Michael Imperiale is currently the Chief Safety Officer at Paradigm Biopharmaceuticals Ltd. He previously worked as the Senior Director-Medical Sciences at Nuvelo, Inc. from 2004 to 2007.
He also held positions as the Senior Director-Global Medical Affairs at BioMarin Pharmaceutical, Inc., Director-Clinical Science at InterMune, Inc., Director-Clinical Trials Development at Exelixis, Inc., and Independent Director at ScripsAmerica, Inc. Additionally, he served as the Senior Associate Director-Clinical Scientific at Boehringer Ingelheim Pharmaceuticals, Inc. from 2000 to 2004.
From 2007 to 2009, he was the Vice President-Clinical Research Operations at Talon Therapeutics, Inc. Dr. Imperiale obtained his undergraduate degree from Villanova University in 1982 and his doctorate degree from Hahnemann University in 1987.